Page last updated: 2024-09-03

4-carbamoylimidazolium 5-olate and Colonic Neoplasms

4-carbamoylimidazolium 5-olate has been researched along with Colonic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukui, M; Inaba, M; Morisada, S; Nakamura, M; Ogino, S; Sakurai, Y; Tsukagoshi, S; Yoshida, N1
Fukui, M; Inaba, M; Morisada, S; Nakamura, M; Sakurai, Y; Tsukagoshi, S1

Other Studies

2 other study(ies) available for 4-carbamoylimidazolium 5-olate and Colonic Neoplasms

ArticleYear
Optimal treatment schedule and antitumor spectrum of 4-carbamoylimidazolium 5-olate (SM-108) in murine tumors.
    Cancer research, 1983, Volume: 43, Issue:12 Pt 1

    Topics: Animals; Carcinoma, Ehrlich Tumor; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation, Preclinical; Imidazoles; Leukemia L1210; Leukemia P388; Mice; Neoplasms, Experimental; Sarcoma 180

1983
[Antitumor activities of orally administered 4-carbamoylimidazolium-5-olate (SM-108)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:10

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Body Weight; Carcinoma, Ehrlich Tumor; Colonic Neoplasms; Drug Administration Schedule; Imidazoles; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred ICR; Neoplasms, Experimental; Sarcoma 180

1985